Siegel Jolie 4
4 · C4 Therapeutics, Inc. · Filed Sep 19, 2023
Insider Transaction Report
Form 4
Siegel Jolie
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-09-18+120,000→ 120,000 totalExercise: $2.15Exp: 2033-09-17→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full on September 18, 2025, subject to the Reporting Person's continued service on such date.